In AML/ETO c-kitmut (A/Ec) leukemia mice, blocking the IL10/IL10R/PI3K/AKT signaling pathway extended their survival and significantly reduced the stemness of A/Ec leukemia cells. The gene discussed is AKT1; the disease is acute myeloid leukemia.